Centricity Vision Inc., a global ophthalmic technology company and developer of the ZEPTO IOL Positioning System, announced the launch of ZEPTO Plus™, a new,...
The U.S. Food and Drug Administration approved Relyvrio (sodium phenylbutyrate/taurursodiol) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig's...
Synaptogenix, Inc., an emerging biopharmaceutical company developing regenerative therapeutics for neurodegenerative disorders, commented on the positive Phase 3 trial results for Lecanemab announced last...
Cell coding company bit.bio has announced an expansion to its product portfolio - ioGlutamatergic Neurons TDP-43M337V disease model and early access to its ioMicroglia...
For nearly 20 years, Bionix has supplied the healthcare industry with its innovative and dependable Lighted Ear Curettes, designed to illuminate and improve visualization...
